Cogent Biosciences Inc. (COGT) Financial Statements (2024 and earlier)

Company Profile

Business Address 275 WYMAN STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments265,710259,276219,684242,19037,42455,671
Cash and cash equivalents53,229139,886219,684242,19037,42455,671
Short-term investments212,481119,390    
Restricted cash and investments  1,255    
Receivables     2,0001,668
Other undisclosed current assets5,0614,4352,9492,7221,16723,663
Total current assets:270,771264,966222,633244,91240,59181,002
Noncurrent Assets
Operating lease, right-of-use asset21,99823,3162,7714,6155,285
Property, plant and equipment8,3447,7831,7061341,8653,251
Long-term investments and receivables 7,460     
Long-term investments 7,460     
Restricted cash and investments   1,2551,2551,2551,255
Other noncurrent assets4,8644,7453,727 427419
Total noncurrent assets:42,66635,8449,4596,0048,8324,925
TOTAL ASSETS:313,437300,810232,092250,91649,42385,927
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:20,97012,3097,1074,7797,1315,477
Employee-related liabilities3,3891,4432,5001,599
Accounts payable10,6555,8423,4837323,1831,519
Accrued liabilities10,3156,4672359848942,079
Other undisclosed accounts payable and accrued liabilities    1,620554280
Deferred revenue     1,315
Debt     1,619 
Contract with customer, liability17,949
Other undisclosed current liabilities17,19814,5409,9708,3153,1831,519
Total current liabilities:38,16826,84917,07713,09413,24824,945
Noncurrent Liabilities
Long-term debt and lease obligation:   8313,1554,413 
Liabilities, other than long-term debt17,46718,226   748
Deferred rent credit      748
Operating lease, liability17,46718,2268313,1554,413
Other undisclosed noncurrent liabilities   (831)(3,155)  
Total noncurrent liabilities:17,46718,2268313,1554,413748
Total liabilities:55,63545,07517,90816,24917,66125,693
Equity
Equity, attributable to parent, including:257,802255,735214,184234,66731,76260,234
Common stock867044323030
Additional paid in capital801,059601,153399,713322,454155,624152,275
Accumulated other comprehensive income (loss)246(104)   (12)
Accumulated deficit(603,624)(411,214)(270,973)(198,700)(123,892)(92,059)
Other undisclosed equity, attributable to parent60,03565,83085,400110,881  
Total equity:257,802255,735214,184234,66731,76260,234
TOTAL LIABILITIES AND EQUITY:313,437300,810232,092250,91649,42385,927

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues9502,6212,4687,87122,4999,734
Sublease income 9502,6212,468770 
Cost of revenue    (49,518)  
Gross profit: 9502,6212,468(41,647)22,4999,734
Operating expenses(208,130)(147,839)(75,551)(40,552)(54,677)(45,739)
Other undisclosed operating loss (950)(2,621)(2,468)   
Operating loss:(208,130)(147,839)(75,551)(82,199)(32,178)(36,005)
Nonoperating income15,7207,5983,2787,3913451,473
Investment income, nonoperating13,0773,9894671442671,153
Other nonoperating income9432,2492,46877978320
Loss from continuing operations:(192,410)(140,241)(72,273)(74,808)(31,833)(34,532)
Loss before gain (loss) on sale of properties:(72,273)(74,808)(31,833)(34,532)
Net loss attributable to parent:(192,410)(140,241)(72,273)(74,808)(31,833)(34,532)
Preferred stock dividends and other adjustments      (16)
Other undisclosed net loss available to common stockholders, basic    (104,400)  
Net loss available to common stockholders, diluted:(192,410)(140,241)(72,273)(179,208)(31,833)(34,548)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(192,410)(140,241)(72,273)(74,808)(31,833)(34,532)
Other comprehensive income (loss)350(104)  124
Comprehensive loss, net of tax, attributable to parent:(192,060)(140,345)(72,273)(74,808)(31,821)(34,528)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: